MRNA financials
Moderna (MRNA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MRNA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.94B | $1.08B | -$3.07B | -$2.82B | -7.26 |
| 2024 | $3.20B | $1.74B | -$3.94B | -$3.56B | -9.27 |
| 2023 | $6.85B | $2.15B | -$4.24B | -$4.71B | -12.34 |
| 2022 | $18.88B | $13.46B | $9.42B | $8.36B | 20.10 |
| 2021 | $17.74B | $15.12B | $13.30B | $12.20B | 28.29 |
| 2020 | $803.39M | $764.21M | -$763.14M | -$747.06M | -1.96 |
- MRNA revenue was $1.94B in fiscal 2025, net income -$2.82B.
Updated 2026-11-02 19:56 UTC